| Literature DB >> 25375333 |
Guan-Ling Xu1, Meng Xie2, Xiao-Yan Yang3, Yan Song4, Cheng Yan5, Yue Yang6, Xia Zhang7, Zi-Zhen Liu8, Yu-Xin Tian9, Yan Wang10, Rui Jiang11, Wei-Rui Liu12, Xiao-Hong Wang13, Gai-Mei She14.
Abstract
Component fingerprints are a recognized method used worldwide to evaluate the quality of traditional Chinese medicines (TCMs). To foster the strengths and circumvent the weaknesses of the fingerprint technique in TCM, spectrum-effect relationships would complementarily clarify the nature of pharmacodynamic effects in the practice of TCM. The application of the spectrum-effect relationship method is crucial for understanding and interpreting TCM development, especially in the view of the trends towards TCM modernization and standardization. The basic requirement for using this method is in-depth knowledge of the active material basis and mechanisms of action. It is a novel and effective approach to study TCMs and great progress has been made, but to make it more accurate for TCM research purposes, more efforts are needed. In this review, the authors summarize the current knowledge about the spectrum-effect relationship method, including the fingerprint methods, pharmacodynamics studies and the methods of establishing relationships between the fingerprints and pharmacodynamics. Some speculation regarding future perspectives for spectrum-effect relationship approaches in TCM modernization and standardization are also proposed.Entities:
Mesh:
Substances:
Year: 2014 PMID: 25375333 PMCID: PMC6271029 DOI: 10.3390/molecules191117897
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Line chart showing the total amount of research articles on the TCM spectrum-effect relationship approach published from 2003 to 2013.
Figure 2The general content of spectrum-effect relationship studies.
Figure 3The spectrum-effect relationship research objects.
Summary of single herb spectrum-effect relationships.
| Chinese Herb Medicine | Processing Method | Fingerprint | Effects | Experimental Model | Analytical Method |
|---|---|---|---|---|---|
| DB | HPLC | Antioxidant effect | Scavenge DPPH radical | HCA [ | |
| DB | UPLC | Antibacterial effect |
| HCA, OMLR, PCA [ | |
| DB | HPLC | Antibacterial effect |
| HCA, PCA, OMLR [ | |
| DB | HPLC | Antioxidant effect | Scavenge DPPH radical | CA [ | |
| DB | HPLC | Reinforcing Qi, Replenishing blood | Mice | GRDA [ | |
| DB | GC | Antitumor effect | Nasopharygeal carcinoma cells | GRDA [ | |
| DB | HPLC | Dispersing blood stasis effect | Mice | GRDA [ | |
| DB | HPLC | Antibacterial effect Anticancer effect | Scavenge DPPH radical | BCA [ | |
| DB | HPLC | Anti-inflammatory effect | RAW 264.7 cells | PLSR [ | |
|
| DE | TLC | Antitumor effect | BGC 803 cancer cells | CA [ |
| DE | HPLC | Cooling blood effect | Rat alveolar macrophage NR 8383 | PLSR [ | |
| DB | UPLC | Anti-HIV-1 effect | HIV-1 reverse transcriptase | PCA [ | |
| DE | HPLC | Tyrosinase inhibitor | Tyrosinase | CA [ | |
| DB | HPLC | Anti-oxidation effect | Fenton reaction | BCA [ | |
| DEC | HPLC | Neuroprotective effects | SH-SY5Y cells | BCA [ | |
| DE | HPLC | Antifungal effect | NCCLS M 38-A | GRDA [ | |
| DB | HPLC | Anti-hepatic fibrosis effect | LX-2 hepatic stellate cells | BCA [ | |
| DE | HPLC | Promotion of melanogenesis effect | Melanoma B 16 cells | GRDA [ | |
| DE | HPLC | Anti-gastrointestinal propulsion effect | Mice | GRDA [ | |
| DEC | UPLC | Protective effect on myocardial cells | Myocardial cells | BCA [ | |
| DB | HPLC | Ameliorating insulin resistanc | 3T3-L1 preadipocyte | PCA,CA,GRDA [ | |
| DB | HPLC | Improving immunity effect | Mice | GRDA [ | |
| DB | HPLC | Antipyretic effect | Rat
| GRDA [ | |
| DE | HPLC | Hepatoprotective effect | Mice | HCA, TCA [ | |
| DB | HPLC | Anti-inflammatory effect | Mice | CA [ | |
| DB | HPLC | Anti-influenza virus effect | MDCK cells | OMLR [ | |
| DE | HPLC | Anti-inflammatory effect | Mice | GRDA [ | |
| DB | IR | Antitumor effect | 7901, Hela cells | OMLR [ | |
| DB | HPLC | Anti-inflammatory effect | Mice | GRDA [ | |
| DE | HPL C | Antioxidant effect | KMnO4 | GRDA, CA, GRNN [ | |
| DE | HPLC | Promote blood circulation | Mice | OMLR [ | |
| DE | HPLC | Sedative-hypnotic effect | Mice | CA [ | |
| DE | HPLC | Hepatoprotective effect | Mice | CA [ | |
| DB | HPLC | Antioxidant effect | Rat | CA [ | |
| DB | HPLC | Eliminate phlegm effect | Mice | GRDA [ | |
| DE | HPLC | Alleviate intestinal cramps effect | Rabbit | CA [ | |
| DE | HPLC | Cytotoxic effect | MGC 80-3, RKO, HepG2 cells | CA [ | |
| DB | HPLC | Anti-myocardial ischemia effect | Rat | CA, FMA, | |
| DPM | UPLC | Mitochondria growth promoting effect | Rat | CA [ | |
| DB | UPLC | Antibacterial effect |
| CA [ |
Abbreviations: DB—different batches; DE—different extracts; DEC—different extracts combination; DPM—different processing methods; HCA—Hierarchical Cluster Analysis; PLSR—Partial Least Squares Regression; OMLR—Ordinary Multiple Linear Regression; CA—Correlation Analysis; GRDA—Gray Regression Degree Analysis; FMA—Fuzzy Mathematical Analysis; PCA—The Primary Component Analysis; BCA—Bivariate Correlation Analysis; GRNN—General Regression Neural Network.
Summary of Chinese herbal formula spectrum-effect relationships (for abbreviations refer to the footnote in Table 1).
| Names | Involved TCMs | Fingerprint | Effects | Experimental Model | Analytical Method |
|---|---|---|---|---|---|
| Baihu Tang | HPLC | Anti-inflammatory effect | Rat | BCA [ | |
| Danggui Chuanxiong | HPLC | Anti-myocardial ischaemia effect | Rat | BCA, OMLR [ | |
| Mongolian Preparation Sendeng-4 Decoction | HPLC | Anti-inflammatory and analgesic effect | Mice | OMLR [ | |
| Compound Wuren chun Capsules | HPLC | Liver protection | Rat | CA [ | |
| Gushu Dan | HPLC | The proliferative effect of osteoblast-like cells | Osteoblast-like cells | BCA, OMLR [ | |
| Tongsaimai Pellet | UPLC | Brain protection | Rat, Rabbit, PC 12 cells | HCA [ | |
| Xiaoyao Wan | HPLC | Anti-tyrosinase effect Anti-depression effect | B 16 melanoma cells | BCA [ | |
| Jia Wei Si Miao Decoction | GC | Anti-inflammatory effect | Mice | OMLR, CA [ | |
| Ling Gui Shu Gan Tang | HPLC | Diuretic effect | Mice | OMLR [ | |
| Shaoyao Gancao formulas | HPLC | Analgesic effect | Mice | CA [ | |
| Qi Zhi Wei Tong | HPLC | Anti-inflammatory effect | RAW 264. 7 cells | GRDA, GRNN [ | |
| Sheng Hua Tang | HPLC | Invigorate the circulation of Qi | Rat | CA [ | |
| Tao Hong Si Wu Tang | GC | Analgesic effect | Mice | OMLR, CA [ | |
| Wu Zhu Yu Tang | HPLC | Analgesic effect | Mice | OMLR [ | |
| Xie Bai San | HPLC | Anti-inflammatory effect | Mice | OMLR, BCA [ | |
| Zuo Jin Wan | HPLC | Biothermo-logical effect |
| CA [ | |
| Da Cheng Qi Tang | HPLC | Purgative effect | Mice | HCA [ |
For the meaning of abbreviations refer to the footnotes in Table 1.
Summary of the spectrum-effect relationships of Chinese medicine preparations and drug-containing sera.
| Names | Type | Fingerprint | Effects | Experimental Model | Analytical Method |
|---|---|---|---|---|---|
| Chinese medicine preparation | HPLC | Antioxidant effect | Scavenge DPPH radical | PLSR [ | |
| San Huang Preparation | Chinese medicine preparation | HPLC | Improve insulin resistance | Rat, The 3T3-L1 preadipocytes cells | OMLR, BCA, PCA [ |
| Xiang Dan Injection | Chinese medicine preparation | HPLC | Anti-myocardial ischemia effect | Rat | GRNN [ |
| Bu Zhong Yi Qi Wan | Serum containing drug | HPLC | Blood enriching effect | Mice | GRDA [ |
| Xiao Yao Fang | Chinese medicine preparation | HPLC | Anti-depression effect | Rat | GRDA [ |
| Chinese medicine preparation | GC | Anti-inflammatory effect | Rat, Mice | HCA [ | |
| Serum containing drug | CE | Increase the coronary artery flow | Rabbit | CA [ |
For the meaning of abbreviations refer to the footnotes in Table 1.
Common analytical methods applied in spectrum-effect relationships.
| Method | Purpose | Advantages | Limits |
|---|---|---|---|
| CA | Study close degree between variable | Determine the relativity degree, significant extent and direction of change | Cannot explain the combined effect of the various peaks corresponding components to the pharmacodynamic indicators |
| HCA | Study the problem of classification, also known as group analysis | Intuitive, concise and achieve the classification | Cannot evaluate the correlation magnitude and the direction between fingerprint peaks and pharmacodynamic indicators |
| OMLR | Study a linear function to clarify the relationship between one dependent and two or more independent variables | Most commonly used method to study the intrinsic link | Not be able to see the contribution of peaks to the efficacy and not suitable for multiple correlation independent variables |
| PLSR | Allow the condition of the number of samples is less than that of variables to do regression modeling | Strong practicality and stability includes; Include all the original peaks of fingerprints | Abstract and difficult to understand; only suitable for qualitative analysis but not to determine the precise quantitative relationship between them |
| GRDA | Analyze the association degree of the various factors in system | Can use the known information to reveal unknown information | Difficult to describe overall contribution of the various peaks corresponding components through pharmacodynamic indicators |
| PCA | Elect fewer important variables from multiple variables through a linear transformation | Without loss of characteristic value number and information of sample | The amount of information after variable dimension reduction maintaining at a high level; The extracted principal component number being less than the original number of variables |
For the meaning of abbreviations refer to the footnotes in Table 1.